How so? If you look at April Symphony Nrx #s they are about 100% more than the Q1 avg. Pretty much all the medicaid deals didn't kick in until April either. Also, it seems ex-USA sales have picked up significantly faster than expected. Hitting $800m in Q4 doesn't seem that difficult. I'd bet a dollar they hit that with ease.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.